2nd Cardiology Department, National and Kapodistrian University of Athens, Attikon Hospital, Rimini 1, 12462, Haidari, Greece.
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, "Alexandra" Hospital, Vassilisis Sofias Avenue 80, 11528, Athens, Greece.
Heart Fail Rev. 2019 Jul;24(4):439-459. doi: 10.1007/s10741-019-09775-4.
Hypertrophic cardiomyopathy (HCM) represents a phenotype of left ventricular hypertrophy unexplained by abnormal loading conditions. The definition is based on clinical criteria; however, there are numerous underlying etiologic factors. The MOGE(S) classification provides a standardized approach for multimodal characterization of HCM. HCM is associated with increased morbidity and mortality, and especially the assessment of the risk of sudden cardiac death is of paramount importance. In this review, we summarize essential knowledge and recently published data on clinical presentation, diagnosis, genetic analyses, differential diagnosis, prognosis, and treatment options that are necessary for understanding and management of HCM.
肥厚型心肌病(HCM)表现为一种左心室肥厚的表型,其原因不能用异常的负荷条件来解释。该定义基于临床标准;然而,有许多潜在的病因因素。MOGE(S)分类为 HCM 的多模式特征提供了一种标准化的方法。HCM 与发病率和死亡率的增加有关,特别是评估心源性猝死的风险至关重要。在这篇综述中,我们总结了理解和管理 HCM 所需的关于临床表现、诊断、基因分析、鉴别诊断、预后和治疗选择的必要的基本知识和最近发表的数据。